ELLIPTA
Sponsors
GlaxoSmithKline
Conditions
AsthmaPulmonary Disease, Chronic Obstructivechronic obstructive airways disease (COPD)
Phase 2
Phase 3
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT01868009
Start: 2013-05-31End: 2013-07-31Updated: 2014-03-04
Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
CompletedNCT04937387
Start: 2021-07-29End: 2024-08-05Updated: 2025-08-11
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
RecruitingNCT05757102
Start: 2023-04-25End: 2027-01-15Target: 292Updated: 2025-10-07
Phase 4
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices
CompletedNCT02184624
Start: 2014-08-28End: 2015-07-31Updated: 2017-05-23
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma
CompletedNCT02195284
Start: 2014-11-30End: 2015-05-31Updated: 2015-11-23
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478683
Start: 2018-06-25End: 2019-03-14Updated: 2020-10-28
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478696
Start: 2018-06-25End: 2019-03-18Updated: 2020-10-28
A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma
CompletedNCT04813354
Start: 2021-04-14End: 2021-07-08Updated: 2023-05-15
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT04923347
Start: 2023-06-06End: 2024-03-14Updated: 2025-03-24
Unknown Phase
An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981)
Active, not recruitingNL-OMON46129
Start: 2017-06-29Target: 360Updated: 2024-02-28
Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness
CompletedNCT03543176
Start: 2018-05-31End: 2019-08-21Updated: 2020-08-05